| Literature DB >> 6976416 |
H C Lane, J H Shelhamer, H S Mostowski, A S Fauci.
Abstract
A human IgMk monoclonal antibody, 2F7, of predetermined specificity, has been produced by the fusion of human peripheral blood lymphocytes with the nonsecreting mouse myeloma line SP-1. The heterohybridoma has remained stable for over 8 mo, with culture supernatants containing up to 30 micrograms/ml of specific IgM. The antibody has been shown to be capable of inducing a blastogenic response in the absence of antigen in the peripheral blood lymphocytes of normal subjects immune to the antigen. The ability to choose an antigen, immunize a human subject to that antigen, and then use the peripheral blood lymphocytes from that subject to produce antigen-specific human monoclonal antibodies should be of great value in a wide variety of investigative, diagnostic, and therapeutic endeavors.UEntities:
Mesh:
Substances:
Year: 1982 PMID: 6976416 PMCID: PMC2186568 DOI: 10.1084/jem.155.1.333
Source DB: PubMed Journal: J Exp Med ISSN: 0022-1007 Impact factor: 14.307